[Antiplatelet and anticoagulant treatment after percutaneous transluminal angioplasty for peripheral arteriosclerosis. Survey of a Cochrane review].
Lorenzen
Nina Dyrberg
ND
Arhus Universitetshospital, Skejby, Hjerte-lunge-karkirurgisk Afdeling T, Karkirurgisk Sektion, Arhus N.
Eldrup
Nikolaj
N
Laustsen
Jesper
J
D000800:Angioplasty, Balloon; D000925:Anticoagulants / Q000627:therapeutic use*; D001161:Arteriosclerosis / Q000188:drug therapy / Q000517:prevention & control / Q000628:therapy; D001241:Aspirin / Q000627:therapeutic use; D004176:Dipyridamole / Q000627:therapeutic use; D019317:Evidence-Based Medicine; D006801:Humans; D016491:Peripheral Vascular Diseases / Q000188:drug therapy / Q000517:prevention & control* / Q000628:therapy; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D012008:Recurrence
D000925:Anticoagulants; D010975:Platelet Aggregation Inhibitors; D004176:Dipyridamole; D001241:Aspirin